Oryzanol A



Compound IDCDAMM01390
Common nameOryzanol A
IUPAC name[7,7,12,16-tetramethyl-15-(6-methylhept-5-en-2-yl)-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
Molecular formulaC40H58O4

Experimental data

Retention time17.4
Adduct[M+H]+
Actual mz603.45
Theoretical mz603.441
Error13.63
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.4992

Identifiers and class information

Inchi keyFODTZLFLDFKIQH-GHRIWEEINA-N
SmilesO=C(OC1CCC23CC43CCC5(C)C(CCC5(C)C4CCC2C1(C)C)C(C)CCC=C(C)C)C=CC6=CC=C(O)C(OC)=C6
SuperclassLipids and lipid-like molecules
ClassSteroids and steroid derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)7
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)10
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)602.896
Computed dipole moment(dipole)1.46
Total solvent accessible surface area (SASA)1029.73
Hydrophobic component of SASA (FOSA)796.646
Hydrophilic component of SASA (FISA)89.752
Pie component of the SASA (PISA)143.333
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1994.7
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)3.5
Free energy of solvation of dipole (dip^2/V)0.0010686
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0033989
Globularity descriptor (glob)0.744207
Predicted polarizability in cubic angstroms (QPpolrz)68.622
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.956
Predicted octanol/gas partition coefficient (QPlogPoct)25.907
Predicted water/gas partition coefficient (QPlogPw)6.489
Predicted octanol/water partition coefficient (QPlogPo/w)10.002
Predicted aqueous solubility (QPlogS)-12.208
Conformation-independent predicted aqueous solubility (CIQPlogS)-10.282
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.355
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1395.65
Predicted brain/blood partition coefficient (QPlogBB)-1.12
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)709.312
Predicted skin permeability, log Kp (QPlogKp)-1.709
PM3 calculated ionization potential (IP(ev))8.876
PM3 calculated electron affinity (EA(eV))0.76
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)3.01
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)62.69
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P05067APPBeta amyloid A4 proteinT87024SEA
P23280CA6Carbonic anhydrase VIT06569SEA
P11926ODC1Ornithine decarboxylaseT60366SEA
O14684PTGESProstaglandin E synthaseT02562SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P11388TOP2ADNA topoisomerase II alphaT17048SEA
Q09472EP300Histone acetyltransferase p300T25956SEA
P49810PSEN2Gamma-secretaseT99204SEA
P10636MAPTMicrotubule-associated protein tauT45593SEA
Q04760GLO1Glyoxalase IT88285SEA
Q16236NFE2L2Nuclear factor erythroid 2-related factor 2T88505SEA
P49768PSEN1Presenilin 1T93105SEA
Q96BI3APH1AGamma-secretaseT99840SEA
Q96BI3APH1AGamma-secretaseT99840SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T87024DI0025Alzheimer disease[ICD-11: 8A20]P05067APP
T87024DI0122Diagnostic imaging[ICD-11: N.A.]P05067APP
T06569DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P23280CA6
T06569DI0372Seborrhoeic dermatitis[ICD-11: EA81]P23280CA6
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T02562DI0025Alzheimer disease[ICD-11: 8A20]O14684PTGES
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T17048DI0012Acute myeloid leukaemia[ICD-11: 2A60]P11388TOP2A
T17048DI0225Kaposi sarcoma[ICD-11: 2B57]P11388TOP2A
T17048DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P11388TOP2A
T25956DI0346Prostate cancer[ICD-11: 2C82]Q09472EP300
T25956DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q09472EP300
T99204DI0320Osteoarthritis[ICD-11: FA00-FA05]P49810PSEN2
T99204DI0380Shoulder lesion[ICD-11: FB53]P49810PSEN2
T99204DI0390Soft tissue disorder[ICD-11: FB56]P49810PSEN2
T45593DI0012Acute myeloid leukaemia[ICD-11: 2A60]P10636MAPT
T45593DI0025Alzheimer disease[ICD-11: 8A20]P10636MAPT
T45593DI0265Mild neurocognitive disorder[ICD-11: 6D71]P10636MAPT
T88285DI0210Influenza[ICD-11: 1E30-1E32]Q04760GLO1
T88505DI0038Ataxic disorder[ICD-11: 8A03]Q16236NFE2L2
T93105DI0320Osteoarthritis[ICD-11: FA00-FA05]P49768PSEN1
T93105DI0380Shoulder lesion[ICD-11: FB53]P49768PSEN1
T93105DI0390Soft tissue disorder[ICD-11: FB56]P49768PSEN1
T99840DI0119Desmoid tumour[ICD-11: 2F7C]Q96BI3APH1A
T99840DI0119Desmoid tumour[ICD-11: 2F7C]Q96BI3APH1A

Copyright © 2025